The three Akt isoforms are functionally distinct. Here we show that their phosphoproteomes also differ, suggesting that their functional differences are due to differences in target specificity. One of the top cellular functions differentiallyregulated by Akt isoforms is RNA processing. IWS1, an RNA processing regulator, is phosphorylated by Akt3 and Akt1 at Ser720/Thr721. The latter is required for the recruitment of SETD2 to the RNA Pol II complex. SETD2 trimethylates histone H3 at K36 during transcription, creating a docking site for MRG15 and PTB. H3K36me3bound MRG15 and PTB regulate FGFR2 splicing, which controls tumor growth and invasiveness downstream of IWS1 phosphorylation. 21/24 nonsmallcelllung carcinomas we analyzed, express IWS1. More important, the stoichiometry of IWS1 phosphorylation in these tumors correlates with the FGFR2 splicing pattern, and with Akt phosphorylation and Akt3 expression. These data identify a novel Akt isoformdependent regulatory mechanism for RNA processing and demonstrate its role in lung cancer.
INTRODUCTION
Akt is an AGC family serinethreonine protein kinase. It is activated by a variety of extracellular and intracellular signals and its activation depends on PtdIns3,4,5P3, and to a lesser extent on PtdIns3,4P2, both of which are products of the phosphoinositide 3kinase (Franke et al., 1995; Manning and Cantley, 2007) . Although the three Akt isoforms, Akt1, Akt2 and Akt3, have been treated by most of the earlier studies as a single entity, recent evidence supports their unique roles in the regulation of cell function (Chen et To determine whether the functional differences between Akt isoforms are due to signaling differences, we employed a system of immortalized lung fibroblasts, which were engineered to express one Akt isoform at a time but are otherwise identical (Ezell et al., 2012; Iliopoulos et al., 2009; Polytarchou et al., 2011 . A phosphoproteomics screen of these cells, identified 606 proteins that are phosphorylated on Akt phosphorylation consensus sites in at least one of the Akt isoformexpressing cells. Analysis of the phosphoproteome data indeed identified signaling pathways and cellular functions preferentially regulated by one or another isoform. One of the differentiallyregulated functions was the posttranscriptional processing of mRNA (RNA metabolism) (Moore and Proudfoot, 2009 ).
One of the differentiallyphosphorylated proteins involved in the regulation of RNA metabolism is IWS1, which is phosphorylated at a conserved phosphorylation site, primarily by Akt3 and Akt1. IWS1 was originally identified in the yeast Saccharomyces Cerevisciae through its interaction with Spt6 (Krogan et al., 2002) , a histone H3/H4 chaperone (Duina, 2011) . Spt6 also binds the C terminal domain (CTD) of the large subunit of RNA Pol II, following the phosphorylation of the latter at Ser2 (Yoh et al., 2007) . Recent studies in mammalian cells revealed that the Spt6/IWS1 complex contains two additional proteins, Aly/REF, an adaptor that contributes to nucleocytoplasmic RNA transport, and SetD2, a histone H3 trimethyl transferase (Yoh et al., 2007; Yoh et al., 2008 . The same studies showed that this complex contributes both to alternative RNA splicing and to nucleocytoplasmic RNA transport.
The regulation of RNA splicing is a complex and poorly understood process. Although some of the splicing events are constitutive, occurring in all cell types independent of external signals, others, also known as alternative splicing events, are conditional. Recent estimates suggest that at least 90% of the metazoan genes are alternatively spliced (Wang et al., 2008) . This gives rise to a proteome that is significantly more complex than the number of genes would suggest. Alternative splicing plays an important role in differentiation and development, as well as in the response of fully differentiated cells to various signals (Kalsotra and Cooper, 2011) . Defects in alternative splicing have been linked to a host of human diseases, primarily neurodegenerative diseases and cancer (Cooper et al., 2009 ). Alternative splicing depends on the interplay of cisacting RNA elements with transacting splicing factors (Chen and Manley, 2009) , and on epigenetic cues, such as DNA methylation and histone modifications (Luco et al., 2011) . However, very little is known about the control of this machinery by cellular signals (Zhou et al., 2012) .
One of the genes that undergo alternative splicing during development and in some cancers is the gene encoding FGF Receptor2 (FGFR2) (Carstens et al., 2000; Warzecha et al., 2009 ). Alternative splicing gives rise to two isoforms of the receptor, the IIIc and the IIIb isoform, of which only the IIIc isoform is recognized by basic FGF (bFGF or FGF2) (Miki et al., 1992) . The IIIc isoform is expressed preferentially in mesenchymal cells, as opposed to epithelial cells (Luco et al., 2010; OrrUrtreger et al., 1993 and promotes cell migration and invasiveness in response to FGF2. Moreover, the FGFR2 IIIb to IIIc switch has been linked to epithelial mesenchymal transition (EMT) and to a migratory and metastatic phenotype in cancer cells (Thiery and Sleeman, 2006) . The FGFR2 alternative splicing discussed above belongs to a subset of alternative splicing events which depend on histone H3 trimethylation at K36 in the body of the target gene and on the polypyrimidine tract binding protein (PTB) (Carstens et al., 2000; Luco et al., 2010 .
The data presented in this report confirmed the differential phosphorylation of IWS1 at Ser720/Thr721 by Akt3 and Akt1 and showed that its phosphorylation at this site is required for the recruitment of SetD2 to the Spt6IWS1 Aly/REF complex. In the absence of SetD2 recruitment to the complex in lung carcinoma cell lines, the trimethylation of histone H3 at K36 in the body of the FGFR2 gene was impaired. This interfered with the recruitment of MRG15, an H3K36me3binding protein and its interacting partner PTB, and shifted the splicing of FGFR2 from the IIIc to the IIIb isoform. The shift in the alternative splicing of FGFR2 interferes with cell migration and invasiveness in response to FGF2 and suppresses the proliferation and invasiveness of tumor cells both in culture and in animals. Addressing the expression of FGFR2 in a set of lungderived normal and tumor samples revealed that whereas the overall expression was similar in both, there was a shift toward the IIIc isoform in the tumor samples. More important, the relative expression of the IIIc and IIIb isoforms in nonsmallcelllung carcinomas (NSCLCs) correlated with the stoichiometry of IWS1 phosphorylation and the latter correlated with Akt phosphorylation and Akt3 expression. Finally, data from "Oncomine" show that the levels of expression of IWS1 in lung cancer correlate with the tumor stage. These findings combined, underpin the importance of this http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947584/ 3/12
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pathway in the pathogenesis of lung cancer. Overall, our data suggest that Akt isoformdependent phosphorylation events are essential for RNA processing and provide novel insights into the role of Akt in carcinogenesis.
RESULTS

Differential regulation of the Aktphosphoproteome by the three Akt isoforms
To investigate signaling differences between Akt isoforms, we performed a phosphoproteomics screen on an isogenic cellular platform, where Aktnull cells were engineered to express one Akt isoform at a time, or a combination of all three (Fig 1A and S1A) . Cell lysates were digested with LysC and the resulting peptides were affinity purified with Akt phosphosubstrate antibodies. Enriched phosphopeptides were digested with trypsin, purified over StageTip and analyzed by mass spectrometry. Comparison of the z scores (Fig S1B) of individual phosphorylation sites revealed significant differences between the phosphoproteomes of Akt1, Akt2, Akt3 and Akt1/2/3 cells (Fig 1B) . To validate these data, we examined the z scores of known phosphorylation events that were also detected in our screen ( Fig 1C and Table S1 ) and we examined and confirmed a set of phosphorylation events first detected in the present study (Fig 1C, S1C-G) . These analyses validated all phosphorylation events above MAD = −0.64. A Venn diagram of Akt1, Akt2, Akt3 and Akt1/2/3mediated phosphorylation events, with zscores above MAD = 2, identified sets of proteins that are differentially phosphorylated by one or another isoform ( Fig S2A) . The subcellular localization of these proteins revealed differences in distribution between isoform specific targets ( Fig S2B) . Moreover, bioinformatics analyses suggested that Akt isoforms differentially regulate canonical pathways and cell functions (Fig 2A and 2B) . One of the functions predicted to be differentially regulated by different Akt isoforms is RNA metabolism, which is represented by 25 proteins that are involved in different stages of the process (Fig 3C and S2C ). One of the proteins we identified as a differentially phosphorylated Akt target was IWS1 (Fig 2D and 2E) , which is known to contribute to the assembly of a transcriptional elongation complex on the Ser2phosphorylated CTD of the large subunit of RNA polymerase II (Yoh et al., 2007; Yoh et al., 2008 . Immunoprecipitation of IWS1 from FlagIWS1transduced lung fibroblasts expressing Akt1, Akt2 or Akt3 with the Akt phosphosubstrate antibody and probing the immunoprecipitates with an antiFlag antibody, confirmed the Akt isoformdependent phosphorylation of IWS1 at a site corresponding to the Akt phosphorylation consensus (Fig 2F) . In agreement with this observation, the inhibition of all Akt activity in HELA cells with 5 μM of the Akt inhibitor MK2206, blocked IWS1 phosphorylation ( Fig 2G) . Finally, in vitro kinase assays using bacterially expressed wild type IWS1 and its phosphorylation site mutants as substrates, confirmed that IWS1 is phosphorylated directly by Akt and that Ser720/Thr721 is the only Akt phosphorylation site in this protein (see supplement for further discussion). Remarkably, IWS1 was phosphorylated by Akt3 and less efficiently by Akt1, but not Akt2, suggesting that isoformdependent phosphorylation specificity may be the result of structural differences that directly affect substrate recognition (Fig 2H and S2D ).
IWS1 phosphorylation at Ser720/Thr721 is required for the recruitment of SetD2 to the RNA polymerase II elongation complex
To determine the biological significance of IWS1 phosphorylation, we first examined its expression in a set of human tumor cell lines. This analysis identified the NSCLC cell lines NCI H522 and NCI H1299 as high expressors and T47D, a human mammary carcinoma cell line as a low expressor (Fig S3A) . Western blotting confirmed that NCI H522 and NCI H1299 cells express higher levels of IWS1 than T47D cells. IGF1 stimulation of these cells revealed that IWS1 phosphorylation is regulated by receptor tyrosine kinasegenerated signals and correlates with activation of Akt ( Fig 3A) .
In parallel experiments NCI H522, NCI H1299 and T47D cells were transduced with shIWS1resistant constructs of FLAGIWS1 or FlagIWS1S720A/T721A. Subsequent infection of these cells with the shIWS1 lentiviral construct gave rise to cell lines in which the endogenous IWS1 was knocked down or replaced by exogenous wild type or mutant IWS1 ( Fig 3B) . The phosphorylation of the wild type protein was confirmed by probing IWS1 immunoprecipitates of wild type and mutant rescue cell lysates with the Akt phosphosubstrate antibody ( Fig 3C, upper panel). Alternatively, lysates from the same cells were probed with the phosphoIWS1 and total IWS1 antibodies ( Fig 3C, lower panel) . The specificity of the phosphoIWS1 antibody was further validated by using it to probe lysates of NCI H1299 and T47D cells, before and after treatment with MK2206 ( Fig S3B) . Fig 3F) , and that IWS1 phosphorylation at Ser720/Thr721 is not required for the binding (Fig 3G and S3D) . ChIP assays for SetD2 in cells transduced with an HASetD2 construct confirmed that IWS1 phosphorylation is required for SetD2 recruitment to the FGFR2 gene ( Fig 3H, 3I and S3E ) and the trimethylation of histone H3 at K36 in exons IIIb and IIIc (Fig 3J and 3K) .
IWS1 phosphorylation at Ser720/Thr721 regulates the alternative splicing of FGFR2
High abundance of histone H3K36me3 in the IIIb exon is a signal for exon skipping, while low abundance of the same mark is a signal for exon inclusion (KolasinskaZwierz et al., 2009). As a result, knocking down SetD2 or IWS1, which is required for the recruitment of SetD2 to the elongation complex, increased the abundance of the IIIb relative to the IIIc transcripts, in NCI H522 and NCI H1299 cells, which express primarily FGFR2 IIIc, but not in T47D cells, which express primarily FGFR2 IIIb (Fig 4A, 4B, S4A and S4B IWS1S720A/T721A ( Figure 4B ). We conclude that IWS1 phosphorylation by Akt3 and Akt1 shifts the balance of FGFR2 splicing toward FGFR2IIIc, by regulating the recruitment of SetD2 to the elongation complex. If the recruitment of SetD2 depends on the phosphorylation of IWS1, as our data indicate, one would expect that overexpression of SetD2 would not rescue the FGFR2 alternative splicing phenotype in shIWS1 and shIWS1/mutant rescue cells. The experiment in figure S4C confirmed the prediction. To address the dependence of FGFR2 alternative splicing on Akt, we treated the cells with 5 μM MK2206, a dose that fully inhibits all Akt isoforms. Akt inhibition reduced H3K36 trimethylation in exons IIIb and IIIc and promoted exon IIIb inclusion in the FGFR2 transcript (Fig 4C) , suggesting that the IWS1 phosphorylation phenotype depends on the activity of Akt. Knocking down different Akt isoforms sequentially or in combination in the same cells not only confirmed this conclusion, but also showed that the skipping of exon IIIb is promoted primarily by Akt3 and Akt1 (Fig 4D) .
The preceding data raised the question whether Akt regulates FGFR2 splicing primarily by phosphorylating IWS1, or whether it also utilizes an alternative pathway. To address this question, we examined the splicing of FGFR2 in MK2206 or DMSOtreated NCI H522 and NCI H1299 cells transduced with the phosphomimetic mutant IWS1S720D/T721E (IWS1DE) or with the empty vector (EV). The results showed that IWS1DE rescues the MK2206induced FGFR2 alternative splicing phenotype (Fig 4E) . The rescue of the MK2206 induced shift in alternative splicing by the Akt independent IWS1DE mutant supports the hypothesis that Akt controls FGFR2 alternative splicing by phosphorylating IWS1 and not through an alternative pathway. Support for this conclusion was provided by the experiment in figure S4D , which showed that none of the Akt isoforms can reverse the shIWS1 or shSetD2induced shifts in FGFR2 splicing, when overexpressed in NCI H522 cells. Although this conclusion is in agreement with all the data in this report however, it should be viewed with caution because Akt overexpression had no effect on FGFR2 alternative splicing even in shControl cells (Fig S4D) , perhaps because NCI H522 cells express sufficient levels of Akt to keep the pathway fully active.
If IGF1 promotes the phosphorylation of IWS1, perhaps through Akt (Fig 3A) , and the phosphorylation of IWS1 shifts the alternative splicing of FGFR2 toward the IIIc isoform, one would expect that treatment of NCI H522 and NCI H1299 cells with IGF1 would decrease the FGFR2 IIIb/IIIc ratio. The experiment in figure 4F confirmed this prediction and provided evidence that Akt regulates FGFR2 alternative splicing by receptor tyrosine kinase induced signals.
IWS1 phosphorylation at Ser720/Thr721 is required for the binding of MRG15 and PTB to the FGFR2 gene
Histone H3K36me3 provides a docking site for MRG15 (Zhang et al., 2006) , a chromodomain protein that interacts with the polypyrimidine track binding protein (PTB) to translate the H3K36me3 mark into a signal that regulates alternative splicing (Luco et al., 2010) . Consistent with the data on SetD2 binding and histone H3K36 trimethylation in the FGFR2 gene (Fig 3) , chromatin IPs in NCI H522 and NCI H1299 cells confirmed that knocking down IWS1 reduces the binding of both MRG15 and PTB and that their binding is restored by wild type, but not the mutant IWS1 (Fig 4G, 4H , 4I, 4J and S4E).
The data in figure 4C confirmed that the regulation of FGFR2 alternative splicing by SetD2 is IWS1 phosphorylationdependent. Since the binding of MRG15 and PTB to target genes depends on histone H3K36 trimethylation, which is mediated by SetD2, these data suggest that MRG15 and PTB would also regulate FGFR2 alternative splicing in an IWS1 phosphorylationdependent manner. This prediction was confirmed with the experiment in figure S4F , which showed that the MK2206induced increase in the IIIb/IIIc ratio is not rescued by MRG15, PTB, or SetD2. We conclude that the regulation of FGFR2 alternative splicing by SetD2, MRG15 and PTB is strictly dependent on IWS1 phosphorylation by Akt.
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Model of the regulation of PTBdependent alternative splicing by IWS1 phosphorylation
Based on the data presented in figures 3 and 4, we propose that IWS1 phosphorylation regulates PTBdependent alternative splicing via the mechanism described in the model in figure 5 . According to this model, IWS1 phosphorylation is required for the recruitment of SetD2 to RNA Pol II. Inhibition of IWS1 phosphorylation prevents the trimethylation of histone H3 at K36 in the body of FGFR2 and perhaps other target genes. This abrogates the recruitment of the histone H3K36me3interacting protein MRG15 and its binding partner PTB and results in shifts in alternative splicing of target genes, such as FGFR2.
Figure 5
Model of the regulation of FGFR2 alternative splicing by IWS1 phosphorylation at Ser720/Thr721 by Akt1 or Akt3
Alternative splicing of FGFR2 induced by IWS1 phosphorylation at Ser720/Thr721 promotes cell migration, invasiveness and proliferation in response to FGF2
The IIIb isoform of FGFR2 is not recognized by FGF2 (bFGF) whereas the IIIc isoform is (Miki et al., 1992 ). This suggested that by shifting FGFR2 splicing from the IIIb to the IIIc isoform, the Akt1/Akt3dependent IWS1 phosphorylation would promote cell migration and proliferation in response to FGF2. Wound healing and transwell filter assays in NCI H1299 and NCI H522 cells confirmed that IWS1 phosphorylation indeed promotes both nondirectional and directional cell migration in the presence of FGF2 (Fig 6A, 6B , S5A and S5C). Similarly, matrigel invasion and cell proliferation assays confirmed that IWS1 phosphorylation promotes cell invasion and proliferation downstream of FGF2 (Fig 6C, S5B , S5C and 6D). To determine whether the expression of the IIIc, as opposed to the IIIb isoform of FGFR2, is responsible for the enhanced migration and proliferation of the shControl and the shIWS1/wt rescue cells, we infected shIWS1transduced NCI H1299 cells with constructs expressing the IIIc or IIIb isoforms. shControl and shIWS1 cells not transduced with the IIIc or IIIb construct were used as controls. Using these cells we showed that whereas the expression of the IIIc isoform rescues fully the impaired migration and invasiveness of cells growing in FGF2supplemented media (Fig 6E, 6F and 6G ), the expression of the IIIb isoform does not (Fig 6I, 6J and 6K ). The IIIc isoform also rescued the impaired proliferation phenotype of the same cells, although only partially (Fig 6H) . A repeat of the cell proliferation experiment in cells growing in DMEM supplemented with 10% serum, revealed that cell proliferation under these conditions is also regulated by IWS1 phosphorylation at Ser720/Thr721 (Fig 6L, 6M and 6N ). Despite that, FGFR2 IIIc overexpression did not rescue the impaired proliferation induced by IWS1 knockdown (Fig S5D) , suggesting that although IWS1 phosphorylation regulates the proliferation of cells growing both in FGF2 and in serum supplemented media, the mechanisms by which it functions in the two culture conditions are not the same. Thus, whereas IWS1 phosphorylation regulates cell proliferation of cells growing in FGF2supplemented media in part by shifting the alternative splicing pattern of FGFR2, in cells growing in serumsupplemented media, it may function by regulating the transcriptional elongation or splicing of other target genes. figure S5E confirmed the prediction. Given our observation that the splicing phenotype of the IWS1 phosphorylation block is not affected by SetD2 overexpression, it is unlikely that it will be affected by MRG15 or PTB. However, the overexpression of these molecules may affect the biological phenotype because they may have additional activities unrelated to RNA splicing. Go to:
To determine the role of IWS1 phosphorylation in oncogenesis, shControl, shIWS1, shIWS1/wt rescue and shIWS1/mutant rescue NCIH1299 cells were injected subcutaneously in nude mice. The inoculated animals were monitored for tumor growth and they were sacrificed 4 weeks later. The results confirmed that IWS1 phosphorylation promotes both the growth and invasiveness of the tumor cells (Fig 7A and S6A) . Immunohistochemical analysis of the xenografts with the validated antiphosphoIWS1 antibody (Fig 3C and Fig  S3B) confirmed the IWS1 phosphorylation in vivo (Fig 7B) .
Figure 7
IWS1 phosphorylation at Ser720/Thr721 in NSCLC Western blotting of cell lysates derived from a set of human lung specimens (2 normal and 24 NSCLCs), revealed that IWS1 is not expressed in normal lung, but is expressed in 21/24 NSCLCs (Fig 7D) . Immunohistochemical staining of a normal lung and NSCLC tissue array (17 and 23 samples respectively) with the antiphosphoIWS1 antibody also revealed increased phosphoIWS1 nuclear staining in a fraction of the tumors (Fig S6B) . Based on these findings, which suggest a potential role for IWS1 in NSCLC, we proceeded to address the expression of FGFR2 IIIb and IIIc in normal lung and NSCLC samples. The results revealed that the overall FGFR2 expression is similar in both, but it shifts toward IIIc in the tumor samples (Fig 7C) . More important, the shift correlates with the phosphorylation of IWS1 and the latter correlates with the phosphorylation of Akt and the expression of Akt3. Plotting the relative stoichiometry of IWS1 phosphorylation (pIWS1(S720)/total IWS1) against the FGFR2 IIIb/IIIc ratio in the 21 NSCLC samples that express IWS1, revealed that whereas tumors with high relative levels of IWS1 phosphorylation have almost universally low IIIb/IIIc ratios, tumors with low relative levels of IWS1 phosphorylation exhibit IIIb/IIIc ratios that are randomly distributed (Fig 7D and 7E ) (p=0.0002, by Levene's test for equality of variances). Plotting the relative stoichiometry of IWS1 phosphorylation against phosphoAkt (Ser 473), or Akt3 (Fig 7E) , also revealed statistically significant correlations (p=0.00636 and p=0.00745 respectively, by Spearman's rank order correlation). Collectively, these data provide strong support to the hypothesis that the phosphorylation of IWS1 plays a major role in the regulation of FGFR2 alternative splicing in primary human NSCLCs and are consistent with our other data showing that the knockdown of Akt1 and Akt3 shifts the splicing of FGFR2 from the IIIc to the IIIb isoform. Since a low IIIb/IIIc ratio has been shown to promote EMT and tumor cell invasiveness (Thiery and Sleeman, 2006) , these data support the hypothesis that Akt promotes cancer progression by phosphorylating IWS1. This conclusion is further supported by data from the oncomine database (Bild et al., 2006) , which reveal a positive correlation between IWS1 expression with tumor stage (Fig S6C) .
DISCUSSION Linking functional differences between Akt isoforms to differences in target specificity
In this paper we focused on a phosphoproteomics screen, which was carried out in a set of lung fibroblast cell lines that express different Akt isoforms but are otherwise identical. The results revealed significant differences in target specificity between Akt isoforms and identified a host of signaling pathways and cellular functions that may be differentially regulated by them (Fig 2A) . Some of the predictions, such as the regulation of insulin and IGF signaling primarily by Akt2 are in agreement with prior literature (Cho et al., 2001 ). Based on these data it is expected that Akt inhibitors may have widely variable therapeutic effects and toxicity, depending on their relative specificity against the three Akt isoforms.
Regulation of RNA processing by Akt isoforms
One of the top functions differentially regulated by Akt isoforms is RNA metabolism, with 25 proteins involved in various steps of the RNA maturation process being phosphorylated by at least one of the three isoforms (  Fig 2B and 2C) . phosphorylation is required for the recruitment of SetD2 to the complex and the trimethylation of histone H3 at K36 in the body of the target genes. Subsequent recruitment of the histone H3K36me3intracting protein MRG15 and its binding partner PTB results in shifts in the alternative splicing of target genes, one of which is FGFR2.
Regulation of alternative RNA splicing by Akt isoforms
The alternative splicing of FGFR2 gives rise to two isoforms, IIIb and IIIc (Carstens et al., 2000; Warzecha et al., 2009 . IIIb is expressed primarily in epithelial cells, while IIIc, which is the isoform induced by IWS1 phosphorylation, is expressed primarily in mesenchymal cells and in invasive and metastatic tumors (Luco et al., 2010; OrrUrtreger et al., 1993 . Of these isoforms, only IIIc is recognized by FGF2 (Miki et al., 1992) . In agreement with these data, lung carcinoma cell lines in which the endogenous IWS1 was replaced with the phosphorylation site mutant, exhibit defects in FGF2induced cell proliferation, migration and invasion. More important, the defects in cell migration and invasiveness were fully rescued by FGFR2 IIIc but not IIIb, while the defect in cell proliferation was rescued partially and only when the cells were grown in FGF2supplemented media. IWS1 phosphorylation and SetD2 recruitment are expected to target more genes, in addition to FGFR2 (Luco et al., 2010) . Moreover, in some of these genes they may promote transcriptional elongation by preventing cryptic intragenic transcription, with or without an effect on RNA splicing (Carvalho et al., 2013) . Based on these considerations, we propose that IWS1 phosphorylation may promote tumor cell proliferation in culture and in animals by regulating RNA splicing, transcriptional elongation, or both on a host of cellular genes.
It has been firmly established that splicing occurs cotranscriptionally and that it is influenced by the imprinting of the premRNA, during the RNA synthesis and processing steps that precede splicing (Moore and Proudfoot, 2009 ).
To explain how the process of transcription may affect splicing, two models have been proposed: the kinetic model, which suggests that slowing the rate of transcription promotes the inclusion of weak exons into the mature mRNA product, and the chromatin modification model, which proposes that histone and DNA modifications regulate the assembly of protein complexes that control splicing (Luco et al., 2011) , although they may also control nucleosome density and the rate of transcriptional elongation.
Our data support the chromatin modification model (Fig 5) and they show how the chromatinregulated RNA splicing machinery is under the control of Akt signals. However, the link between chromatin modifications and alternative splicing may be more complex than the model indicates. This is suggested by the following observations. In mesenchymal cells, which express the IIIc isoform of FGFR2, histone H3 trimethylation at K36 is accompanied by the downregulation of histone H3K4 and H3K27 trimethylation, and by histone H3K4 mono and dimethylation (Luco et al., 2010) . More important, overexpression of the histone H3K4 methyltransferase ASH2 in these cells, increases the usage of the normally repressed exon IIIb, suggesting that H3K4 trimethylation may also contribute to the regulation of PTBdependent alternative splicing (Luco et al., 2010) . Other studies provided evidence linking MRG15 to the acetylation of histone H4 at K16 (Conrad et al., 2012 ) and perhaps K12 (Pena et al., 2011 ) during transcriptional elongation. MRG15 is a component of several chromatinmodifying complexes, which could give rise to these chromatin modifications. Thus, it has been shown that MRG15 bound to the H3K36me3 mark in the body of transcribed genes (Zhang et al., 2006) , also interacts with the histone H3K4me3/me2 demethylase KDM5B (Xie et al., 2011) , the histone H4K16 acetyltransferase complex NuA4 (mammalian Tip60) (Cai et al., 2003) , the histone H4K16 deacetylase complex Rpd3S (mammalian HDCA2) (Kumar et al., 2011) , and VEZF1 (Gowher et al., 2012), a known regulator of alternative splicing. Some of these interactions may take place in the context of larger complexes, such as the LAF and RLAF complexes (Moshkin et al., 2009 ). It has not been determined yet whether these histone modifications are also observed in the context of the Akt3/Akt1dependent shift in the alternative splicing of FGFR2. If they do, the system we established will allow us to determine whether they play an obligatory role in this process, and to address the epistatic relationships between them.
Relevance of IWS1 phosphorylation in lung cancer
It is now universally accepted that Akt plays a major role in oncogenesis. Experiments, both in culture and in animals, presented in this report, revealed that IWS1 phosphorylation by Akt3 and Akt1 regulates RNA splicing and perhaps transcriptional elongation and represents an important event in lung cancer. Analysis of sets of normal lung and lung cancer samples for the expression of FGFR2 revealed that the overall expression is similar in both.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947584/ 9/12
However, the expression was shifted toward the IIIc isoform in the tumor samples. More important, the shift toward the IIIc isoform was found to correlate with the stoichiometry of IWS1 phosphorylation, which in turn correlates with Akt phosphorylation and Akt3 expression. Overall, this study identifies perturbations in RNA splicing and perhaps transcriptional elongation as a novel mechanism by which Akt promotes oncogenesis, it shows that Akt isoforms contribute to oncogenesis as upstream regulators of FGF2 signaling, and provides direct evidence linking IWS1 to lung cancer.
In summary, data presented in this report link Akt isoformspecific signaling with chromatin modifications occurring in the body of the gene encoding FGFR2, and perhaps other actively transcribed target genes. These chromatin modifications in turn, regulate alternative splicing and transcriptional elongation. By regulating these processes, IWS1 phosphorylation profoundly alters the biology of tumor cells. Interruption of IWS1 phosphorylation suppresses the proliferation, migration and invasiveness of tumor cells both in culture and in animals. Overall, this study provides new insights into the regulation of alternative splicing, a process that plays a critical role in differentiation and development and in a multitude of human diseases, including cancer.
EXPERIMENTAL PROCEDURES
For details, see supplement
Cells, culture, growth factors and Akt inhibitors
Mouse lung fibroblasts were described previously (Iliopoulos et al., 2009) . Culture conditions, cell transfections and infections are described in the supplement.
Phosphoproteomics screen and data analysis
The phosphoproteomics screen and data analysis are presented in the supplement. The origin of the siRNAs, shRNAs and expression constructs is described in Supplementary Table S3 . Cloning and sitedirected mutagenesis were carried out using standard procedures.
Immunoprecipitation, Immunoblotting and in vitro kinase assays
Immunoprecipitation, immunoblotting and in vitro kinase assays are described in the supplement. The phosphorylation substrates (IWS1 wt and IWS1S720A/T721A) were expressed as GST fusions in E Coli, BL21. GSK3α/β was purchased from Cell Signaling Technology (Danvers, MA).
Realtime RTPCR cDNA was synthesized from 1.0 μg of Trizolextracted total cell RNA, using oligodT priming and the Retroscript reverse transcription kit from Ambion. Gene expression was quantified by real time RTPCR.
Chromatin Immunoprecipitation (ChIP)
ChIP assays, using the Millipore kit (cat no. 17295), were done as described in the supplement.
Cell proliferation, migration and invasion assays
Cell proliferation was monitored with the 3(4,5dimethylthiazol2yl)2,5diphenyltetrazolium bromide (MTT) assay. Nondirectional migration was measured with the wound healing assay and directional migration with the transwell filter assay (Kottakis et al., 2011) In vitro invasion was measured using BD BioCoat Matrigel Invasion Chambers (BD Biosciences)
Tumor xenografts
Nude mice injected subcutaneously with 2×10 shControl, shIWS1, shIWS1wt rescue or shIWS1mut rescue NCI H1299 cells, were monitored for a total of 4 weeks..
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Immunohistochemistry A human lung tumor tissue array and xenograft tumors were stained with the specific antiphosphoIWS1 (Ser720) antibody as described in the supplement.
HIGHLIGHTS
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